XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Common Shares
Common Shares
Class A Common Shares
Common Shares
Class B Common Shares
Preferred Shares
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Distributions in Excess of Net Income
Total Shareholders' Equity
Noncontrolling Interest
Consolidated joint venture
Noncontrolling Interest
Common Shares
Total Equity
Balance at Dec. 31, 2019     $ 387 $ 0 $ 147 $ 1,144,808 $ 1,010 $ (338,695) $ 807,657 $ 3,196 $ 64,144 $ 871,801
Balance (in shares) at Dec. 31, 2019   38,652,650     14,703,214           4,279,946  
Increase (Decrease) in Stockholders' Equity                        
Unit Conversion           (30)     (30)     (30)
Dividends and Distributions declared:                        
Preferred Stock               (1,007) (1,007)     (1,007)
Dividend Reinvestment Plan $ 14         14     14     14
Dividend Reinvestment Plan (in shares)   1,094                    
Share Based Compensation:                        
Grants     1     0     1   $ 0 1
Grants (in shares)   135,627                 1,101,924  
Amortization           1,303     1,303   $ 4,466 5,769
Change in Fair Value of Derivative Instruments (30,941)           (28,107)   (28,107)   (2,834) (30,941)
Adjustment to Record Noncontrolling Interest at Redemption Value           3,196     3,196 (3,196)   3,196
Net (loss) income (97,752)             (87,691) (87,691)   (10,061) (97,752)
Balance at Jun. 30, 2020     388 0 $ 147 1,149,291 (27,097) (427,393) 695,336 0 $ 55,715 751,051
Balance (in shares) at Jun. 30, 2020   38,789,371     14,703,214           5,381,870  
Balance at Mar. 31, 2020     387 0 $ 147 1,145,450 (26,411) (362,777) 756,796 3,196 $ 59,162 815,958
Balance (in shares) at Mar. 31, 2020   38,673,242     14,703,214           4,279,946  
Increase (Decrease) in Stockholders' Equity                        
Issuance Costs           (10)     (10)     (10)
Share Based Compensation:                        
Grants     1           1     1
Grants (in shares)   116,129                 1,101,924  
Amortization           655     655   $ 3,823 4,478
Change in Fair Value of Derivative Instruments (792)           (686)   (686)   (106) (792)
Adjustment to Record Noncontrolling Interest at Redemption Value           3,196     3,196 (3,196)   3,196
Net (loss) income (71,780)             (64,616) (64,616)   (7,164) (71,780)
Balance at Jun. 30, 2020     388 0 $ 147 1,149,291 (27,097) (427,393) 695,336 0 $ 55,715 751,051
Balance (in shares) at Jun. 30, 2020   38,789,371     14,703,214           5,381,870  
Balance at Dec. 31, 2020 672,249   389 0 $ 147 1,150,985 (19,275) (509,243) 623,003 0 $ 49,246 672,249
Balance (in shares) at Dec. 31, 2020   38,843,482     14,703,214           5,392,808  
Increase (Decrease) in Stockholders' Equity                        
Unit Conversion     2     2,870     2,872   $ (2,872)  
Unit Conversion (in shares)   225,000                 (225,000)  
Dividends and Distributions declared:                        
Preferred Stock               (36,262) (36,262)     (36,262)
Dividend Reinvestment Plan 0                      
Share Based Compensation:                        
Grants     1     356     357   $ 1,683 2,040
Grants (in shares)   148,993                 794,683  
Amortization           1,414     1,414   $ 2,326 3,740
Change in Fair Value of Derivative Instruments (9,163)           8,251   8,251   912 9,163
Adjustment to Record Noncontrolling Interest at Redemption Value           (1,968)     (1,968) 1,968   (1,968)
Equity Contribution to Consolidated Joint Venture                   158    
Net (loss) income (14,433)             (11,652) (11,652) (158) (2,623) (14,275)
Balance at Jun. 30, 2021 634,687   392 0 $ 147 1,153,657 (11,024) (557,157) 586,015 1,968 $ 48,672 634,687
Balance (in shares) at Jun. 30, 2021   39,217,475     14,703,214           5,962,491  
Balance at Mar. 31, 2021     391 0 $ 147 1,154,579 (12,509) (530,535) 612,073 0 $ 49,172 661,245
Balance (in shares) at Mar. 31, 2021   39,132,307     14,703,214           5,943,014  
Dividends and Distributions declared:                        
Preferred Stock               (6,044) (6,044)     (6,044)
Share Based Compensation:                        
Grants     1     365     366   $ 65 431
Grants (in shares)   85,168                 19,477  
Amortization           681     681   $ 1,468 2,149
Change in Fair Value of Derivative Instruments 2,398           1,485   1,485   912 2,397
Adjustment to Record Noncontrolling Interest at Redemption Value           (1,968)     (1,968) 1,968   (1,968)
Net (loss) income (23,523)             (20,578) (20,578) 0 (2,945) (23,523)
Balance at Jun. 30, 2021 $ 634,687   $ 392 $ 0 $ 147 $ 1,153,657 $ (11,024) $ (557,157) $ 586,015 $ 1,968 $ 48,672 $ 634,687
Balance (in shares) at Jun. 30, 2021   39,217,475     14,703,214           5,962,491